LUCD — Lucid Diagnostics Cashflow Statement
0.000.00%
Last trade - 00:00- $42.73m
- $77.26m
- $2.43m
Annual cashflow statement for Lucid Diagnostics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.42 | -8.28 | -28.1 | -56.2 | -52.7 |
| Depreciation | |||||
| Non-Cash Items | 0.174 | 0.065 | 9.6 | 15.6 | 11.7 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.89 | 2.59 | 0.807 | 8.91 | 5.67 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Cash from Operating Activities | -2.36 | -5.63 | -17.7 | -29.7 | -32.8 |
| Capital Expenditures | 0 | 0 | -0.862 | -0.908 | -0.221 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | -3.2 | 0 |
| Acquisition of Business | |||||
| Cash from Investing Activities | 0 | 0 | -0.862 | -4.11 | -0.221 |
| Financing Cash Flow Items | 2.5 | 5.58 | 2.08 | 0 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.5 | 5.58 | 72.1 | 2.61 | 29.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.139 | -0.045 | 53.5 | -31.2 | -3.58 |